<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; tragedy</title>
	<atom:link href="http://www.tapanray.in/tag/tragedy/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>When ‘Vikshit Bharat’ Rings Hollow: A Tragedy That Exposes India’s Uneven Progress</title>
		<link>http://www.tapanray.in/when-vikshit-bharat-rings-hollow-a-tragedy-that-exposes-indias-uneven-progress/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=when-vikshit-bharat-rings-hollow-a-tragedy-that-exposes-indias-uneven-progress</link>
		<comments>http://www.tapanray.in/when-vikshit-bharat-rings-hollow-a-tragedy-that-exposes-indias-uneven-progress/#comments</comments>
		<pubDate>Fri, 10 Oct 2025 11:25:53 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[cough]]></category>
		<category><![CDATA[death]]></category>
		<category><![CDATA[domestic]]></category>
		<category><![CDATA[export]]></category>
		<category><![CDATA[hollow]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Quality]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[rings]]></category>
		<category><![CDATA[syrup]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[tragedy]]></category>
		<category><![CDATA[Vikshit Bharat]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10978</guid>
		<description><![CDATA[India’s vision of Vikshit Bharat promises inclusive growth and modern progress. Yet, when children die from contaminated cough syrup, that dream rings hollow. This article asks the hard question: can a nation truly be “developed” when its weakest citizens still fall victim &#8230; <a href="http://www.tapanray.in/when-vikshit-bharat-rings-hollow-a-tragedy-that-exposes-indias-uneven-progress/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/when-vikshit-bharat-rings-hollow-a-tragedy-that-exposes-indias-uneven-progress/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Is Fraud or Negligence in Drug Quality Standards Not a Fraud on Patients?</title>
		<link>http://www.tapanray.in/is-fraud-or-negligence-in-drug-quality-standards-not-a-fraud-on-patients/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=is-fraud-or-negligence-in-drug-quality-standards-not-a-fraud-on-patients</link>
		<comments>http://www.tapanray.in/is-fraud-or-negligence-in-drug-quality-standards-not-a-fraud-on-patients/#comments</comments>
		<pubDate>Mon, 03 Jun 2013 00:00:06 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[abbott]]></category>
		<category><![CDATA[Americans]]></category>
		<category><![CDATA[anywhere]]></category>
		<category><![CDATA[Baxter]]></category>
		<category><![CDATA[Boehringer]]></category>
		<category><![CDATA[branded]]></category>
		<category><![CDATA[breach]]></category>
		<category><![CDATA[cadila]]></category>
		<category><![CDATA[chain]]></category>
		<category><![CDATA[charitable]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Claris]]></category>
		<category><![CDATA[contamination]]></category>
		<category><![CDATA[DCGI]]></category>
		<category><![CDATA[Dewas]]></category>
		<category><![CDATA[Dr. Reddy's]]></category>
		<category><![CDATA[DRL]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[everywhere]]></category>
		<category><![CDATA[facilities]]></category>
		<category><![CDATA[fraud]]></category>
		<category><![CDATA[generic]]></category>
		<category><![CDATA[GlaxoSmithKline]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[Heparin]]></category>
		<category><![CDATA[Hospira]]></category>
		<category><![CDATA[Hospital]]></category>
		<category><![CDATA[IMA]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[Ingelheim]]></category>
		<category><![CDATA[ingredients]]></category>
		<category><![CDATA[Integrity]]></category>
		<category><![CDATA[Jaslok]]></category>
		<category><![CDATA[Jubilant]]></category>
		<category><![CDATA[Lupin]]></category>
		<category><![CDATA[manufacturing]]></category>
		<category><![CDATA[Medical Association]]></category>
		<category><![CDATA[Mumbai]]></category>
		<category><![CDATA[OSCS]]></category>
		<category><![CDATA[paonta]]></category>
		<category><![CDATA[pew]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[plants]]></category>
		<category><![CDATA[prescription]]></category>
		<category><![CDATA[Project]]></category>
		<category><![CDATA[Quality]]></category>
		<category><![CDATA[Ranbaxy]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[sahib]]></category>
		<category><![CDATA[Schering-Plough]]></category>
		<category><![CDATA[SCS]]></category>
		<category><![CDATA[Security]]></category>
		<category><![CDATA[Show]]></category>
		<category><![CDATA[stakeholder]]></category>
		<category><![CDATA[standards]]></category>
		<category><![CDATA[Supply]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[tolerance]]></category>
		<category><![CDATA[tragedy]]></category>
		<category><![CDATA[trusts]]></category>
		<category><![CDATA[USFDA]]></category>
		<category><![CDATA[wockhardt]]></category>
		<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[zero]]></category>
		<category><![CDATA[Zydus]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=2607</guid>
		<description><![CDATA[As we know, a substance is called a drug when it has scientifically proven and well documented efficacy and safety profile to reduce both mortality and morbidity of patients. Any fraud or negligence in the drug quality standards, for whatever &#8230; <a href="http://www.tapanray.in/is-fraud-or-negligence-in-drug-quality-standards-not-a-fraud-on-patients/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/is-fraud-or-negligence-in-drug-quality-standards-not-a-fraud-on-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The importance of ‘Supply Chain Integrity’ in ‘Global Supply Chain Management (GSCM)’ process</title>
		<link>http://www.tapanray.in/the-importance-of-supply-chain-integrity-in-global-supply-chain-management-gscm-process/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-importance-of-supply-chain-integrity-in-global-supply-chain-management-gscm-process</link>
		<comments>http://www.tapanray.in/the-importance-of-supply-chain-integrity-in-global-supply-chain-management-gscm-process/#comments</comments>
		<pubDate>Mon, 29 Nov 2010 01:00:07 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[chain]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[GSCM]]></category>
		<category><![CDATA[Heparin]]></category>
		<category><![CDATA[importance]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Integrity]]></category>
		<category><![CDATA[management]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[process]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[SCS]]></category>
		<category><![CDATA[Supply]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[tragedy]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=342</guid>
		<description><![CDATA[Since the last decade with increasing pace of change, mostly in the western world has accelerated the globalization process in the Pharmaceutical Industry across the world. The key drivers to these changes are as follows: 1. A large number of &#8230; <a href="http://www.tapanray.in/the-importance-of-supply-chain-integrity-in-global-supply-chain-management-gscm-process/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-importance-of-supply-chain-integrity-in-global-supply-chain-management-gscm-process/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>To avoid “Heparin” like tragedy in future, a robust “supply chain integrity and security” system is of critical importance</title>
		<link>http://www.tapanray.in/to-avoid-heparin-like-tragedy-in-future-a-robust-supply-chain-integrity-and-security-system-is-of-critical-importance/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=to-avoid-heparin-like-tragedy-in-future-a-robust-supply-chain-integrity-and-security-system-is-of-critical-importance</link>
		<comments>http://www.tapanray.in/to-avoid-heparin-like-tragedy-in-future-a-robust-supply-chain-integrity-and-security-system-is-of-critical-importance/#comments</comments>
		<pubDate>Mon, 29 Mar 2010 00:30:14 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[avoid]]></category>
		<category><![CDATA[chain]]></category>
		<category><![CDATA[critical]]></category>
		<category><![CDATA[future]]></category>
		<category><![CDATA[Heparin]]></category>
		<category><![CDATA[importance]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[Integrity]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[like]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Robust]]></category>
		<category><![CDATA[SCM]]></category>
		<category><![CDATA[SCS]]></category>
		<category><![CDATA[Security]]></category>
		<category><![CDATA[Supply]]></category>
		<category><![CDATA[system]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[tragedy]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=448</guid>
		<description><![CDATA[Globally the pharmaceutical industry is going through a metamorphosis. The types of changes that are taking place today globally, perhaps has no precedence.. The key drivers of these changes are mainly the following: 1. A large number of patent expiration &#8230; <a href="http://www.tapanray.in/to-avoid-heparin-like-tragedy-in-future-a-robust-supply-chain-integrity-and-security-system-is-of-critical-importance/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/to-avoid-heparin-like-tragedy-in-future-a-robust-supply-chain-integrity-and-security-system-is-of-critical-importance/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
